Search by Drug Name or NDC

    NDC 50458-0028-02 Spravato 28 mg/.2mL Details

    Spravato 28 mg/.2mL

    Spravato is a NASAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Pharmaceuticals Inc.. The primary component is ESKETAMINE HYDROCHLORIDE.

    Product Information

    NDC 50458-0028
    Product ID 50458-028_088b53cb-a931-d9a7-e063-6294a90afb43
    Associated GPIs 5811002010C520 5811002010C530
    GCN Sequence Number 079563
    GCN Sequence Number Description esketamine HCl SPRAY 28 MG NASAL
    HIC3 H8Z
    HIC3 Description ANTIDEPRESSANT - NMDA RECEPTOR ANTAGONIST
    GCN 46077
    HICL Sequence Number 041003
    HICL Sequence Number Description ESKETAMINE HCL
    Brand/Generic Brand
    Proprietary Name Spravato
    Proprietary Name Suffix n/a
    Non-Proprietary Name Esketamine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route NASAL
    Active Ingredient Strength 28
    Active Ingredient Units mg/.2mL
    Substance Name ESKETAMINE HYDROCHLORIDE
    Labeler Name Janssen Pharmaceuticals Inc.
    Pharmaceutical Class n/a
    DEA Schedule CIII
    Marketing Category NDA
    Application Number NDA211243
    Listing Certified Through 2024-12-31

    Package

    NDC 50458-0028-02 (50458002802)

    NDC Package Code 50458-028-02
    Billing NDC 50458002802
    Package 2 BLISTER PACK in 1 KIT (50458-028-02) / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00)
    Marketing Start Date 2019-03-05
    NDC Exclude Flag N
    Pricing Information N/A